Less than a month after the US Food and Drug Administration said a TV advertisement for Novo Nordisk A/S’ Wegovy weight-loss ...

The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its ​blockbuster diabetes drug, Ozempic, ...

A Belgian startup's parody ad around a dystopian world where humans power the very AI that took their employment and purpose went viral. For some, it hit a little too close to home. Business Insider ...

Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans. By Paula Span Tamar Abrams had a lousy couple of years in 2022 ...

SNL has spent decades roasting the advertising world, and some of its fake commercials are funnier, sharper, and more memorable than the real thing. From bizarre food products to painfully accurate ...

When Terra Field started taking Wegovy for weight loss in 2022, she finally understood what satiety truly felt like. “It felt the way I thought my body should have been operating the entire time,” ...

President Donald Trump on Thursday announced the launch of TrumpRx — a direct-to-consumer website that is key to his administration's efforts to lower prescription drug costs in the U.S. The site is ...

President Donald Trump put his personal stamp Thursday night on a new government website, TrumpRx, aimed at helping Americans buy medicines at lower prices. "This is a very big deal," Trump said Feb.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. John Wilkerson is a ...

The AI-chatbot marketing wars are kicking into high gear as Anthropic, the startup behind Claude, takes aim at rival OpenAI in its Super Bowl advertising debut. Its big-game commercial parodies the ...

An underrated mission in the music industry is making listeners laugh. Are there a ton of joke and parody songs out there? Yes, but we, and likely many others, would like to see more of them.

Moderna has out-licensed a rare disease drug candidate to Recordati, accepting $50 million upfront for an asset that could deliver registrational data this year. Recordati, an Italian company that ...